产品封面图
文献支持

Recombinant Human BCL9 Protein

, N-His-KSI
收藏
  • ¥1868
  • abinScience
  • France
  • HA753012
  • 2025年08月01日
    avatar
  • 企业认证

    点击 QQ 联系

    • 详细信息
    • 文献和实验
    • 技术资料
    • 保存条件

      Lyophilized from a solution in PBS pH 7.4, 1 mM EDTA, 4% Trehalose, 1% Mannitol.

    • 保质期

      1 year

    • 英文名

      Recombinant Human BCL9 Protein, N-His-KSI

    • 库存

      999

    • 供应商

      abinScience

    • 规格

      100ug

    产品细节图片1

    Product nameRecombinant Human BCL9 Protein, N-His-KSI
    Catalog No.HA753012
    FormLyophilized
    Storage bufferLyophilized from a solution in PBS pH 7.4, 1 mM EDTA, 4% Trehalose, 1% Mannitol.
    Purity>90% as determined by SDS-PAGE.
    ApplicationsELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
    Endotoxin levelPlease contact with the lab for this information.
    Expression systemE. coli
    AccessionO00512
    ReconstitutionReconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details.
    Alternative NamesB-cell CLL/lymphoma 9 protein; B-cell lymphoma 9 protein; Bcl-9; Protein legless homolog; BCL9
    SpeciesHomo sapiens (Human)
    ShippingIn general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.

    abinScience, founded in 2023 in Strasbourg, France, is committed to developing and producing high-quality life science reagents. Rooted in one of Europe’s leading hubs for scientific innovation, abinScience empowers global research through reliable, efficient experimental solutions. Guided by the vision of “Empowering Bioscience Discovery,” we support scientists worldwide in advancing the frontiers of bioscience.

     

    Technology and Innovation

    Relying on the global leading position in antibody and protein research and more than 20 years of industry experience of its parent company ProteoGenix since 2003...

     

    Product categories and application fields.

    Main products...
    Application field: Infectious disease research, Neuroscience, Immunology, Oncology

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    图标文献和实验
    该产品被引用文献
    • Targeting BCL9/BCL9L enhances antigen presentation by promoting conventional type 1 dendritic cell (cDC1) activation and tumor infiltration., PMID:38811552
    • Recent advances in β-catenin/BCL9 protein-protein interaction inhibitors., PMID:33849283
    • A novel β-catenin/BCL9 complex inhibitor blocks oncogenic Wnt signaling and disrupts cholesterol homeostasis in colorectal cancer., PMID:35486727
    • BCL9 regulates CD226 and CD96 checkpoints in CD8+ T cells to improve PD-1 response in cancer., PMID:34417435
    • BCL9/BCL9L in hepatocellular carcinoma: will it or Wnt it be the next therapeutic target?, PMID:32488834
    • BCL9/BCL9L promotes tumorigenicity through immune-dependent and independent mechanisms in triple negative breast cancer., PMID:33767438
    • The Wnt-dependent and Wnt-independent functions of BCL9 in development, tumorigenesis, and immunity: Implications in therapeutic opportunities., PMID:37692512
    • The BCL9-2 proto-oncogene governs estrogen receptor alpha expression in breast tumorigenesis., PMID:25149534
    • BCL9 provides multi-cellular communication properties in colorectal cancer by interacting with paraspeckle proteins., PMID:31911584
    • Genomic analyses identify recurrent MEF2D fusions in acute lymphoblastic leukaemia., PMID:27824051
    相关实验
    图标技术资料

    暂无技术资料 索取技术资料

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    ¥1268
    普健生物(武汉)科技有限公司
    2025年07月12日询价
    ¥500
    北京百奥创新科技有限公司
    2025年06月13日询价
    ¥1280
    武汉益普生物科技有限公司
    2025年12月06日询价
    ¥1880
    武汉佰乐博生物技术有限公司
    2025年07月07日询价
    ¥2450
    武汉菲恩生物科技有限公司
    2026年01月06日询价
    文献支持
    Recombinant Human BCL9 Protein, N-His-KSI
    ¥1868